BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 16728969)

  • 1. Regulatory perspective on clinical trials and end points for female sexual dysfunction, in particular, hypoactive sexual desire disorder: formulating recommendations in an environment of evolving clinical science.
    Shames D; Monroe SE; Davis D; Soule L
    Int J Impot Res; 2007; 19(1):30-6. PubMed ID: 16728969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Testosterone therapy in women: its role in the management of hypoactive sexual desire disorder.
    Abdallah RT; Simon JA
    Int J Impot Res; 2007; 19(5):458-63. PubMed ID: 17581596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Krapf JM; Simon JA
    Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The testosterone patch for women.
    Kingsberg SA
    Int J Impot Res; 2005; 17(5):465-6. PubMed ID: 16049522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Let's talk about sex--and drugs.
    Enserink M
    Science; 2005 Jun; 308(5728):1578. PubMed ID: 15947172
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory issues in female sexual dysfunction.
    Fourcroy JL
    Int J Impot Res; 2007; 19(5):526-9. PubMed ID: 17786156
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrinsa fails to impress FDA advisory panel.
    Spark RF
    Int J Impot Res; 2005; 17(3):283-4. PubMed ID: 15772684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of testosterone in the treatment of hypoactive sexual desire disorder.
    Schwenkhagen A; Studd J
    Maturitas; 2009 Jun; 63(2):152-9. PubMed ID: 19359109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Female hypoactive sexual desire disorder due to androgen deficiency: clinical and psychometric issues.
    Warnock JK; Bundren JC; Morris DW
    Psychopharmacol Bull; 1997; 33(4):761-6. PubMed ID: 9493489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone supplementation for hypoactive sexual desire disorder in women.
    Woodis CB; McLendon AN; Muzyk AJ
    Pharmacotherapy; 2012 Jan; 32(1):38-53. PubMed ID: 22392827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The causes and prevalence of hypoactive sexual desire disorder: part I.
    Feldhaus-Dahir M
    Urol Nurs; 2009; 29(4):259-60, 263. PubMed ID: 19718942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone patches for female sexual dysfunction.
    Drug Ther Bull; 2009 Mar; 47(3):30-4. PubMed ID: 19261838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
    Gregersen N; Jensen PT; Giraldi AE
    Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To study hypoactive sexual desire disorder in a fragile X carrier female successfully treated with local testosterone application.
    Raza S; Baig M; Ali J; Rizvi S
    Int J Impot Res; 2008; 20(2):226-8. PubMed ID: 17851581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient scenario: a 53-year-old woman with hypoactive sexual desire disorder.
    Palacios S; Graziottin A
    Maturitas; 2009 Jun; 63(2):164-8. PubMed ID: 19487091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
    Shifren JL; Davis SR; Moreau M; Waldbaum A; Bouchard C; DeRogatis L; Derzko C; Bearnson P; Kakos N; O'Neill S; Levine S; Wekselman K; Buch A; Rodenberg C; Kroll R
    Menopause; 2006; 13(5):770-9. PubMed ID: 16932240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial comments on "the current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women".
    Goldstein I
    J Sex Med; 2008 Sep; 5 Suppl 4():177-8. PubMed ID: 18783531
    [No Abstract]   [Full Text] [Related]  

  • 18. Testosterone therapy for sexual dysfunction in postmenopausal women.
    Hubayter Z; Simon JA
    Climacteric; 2008 Jun; 11(3):181-91. PubMed ID: 18568783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drugs in early clinical development for the treatment of female sexual dysfunction.
    Belkin ZR; Krapf JM; Goldstein AT
    Expert Opin Investig Drugs; 2015 Feb; 24(2):159-67. PubMed ID: 25376023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoactive sexual desire disorder: inventing a disease to sell low libido.
    Meixel A; Yanchar E; Fugh-Berman A
    J Med Ethics; 2015 Oct; 41(10):859-62. PubMed ID: 26124287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.